McPherson S - Search Results

1

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.

McPherson S, Wilkinson N, Tiniakos D, Wilkinson J, Burt AD, McColl E, Stocken DD, Steen N, Barnes J, Goudie N, Stewart S, Bury Y, Mann D, Anstee QM, Day CP. McPherson S, et al. PLoS One. 2017 Apr 18;12(4):e0175717. doi: 10.1371/journal.pone.0175717. eCollection 2017. PLoS One. 2017. PMID: 28419124 Free PMC article. Clinical Trial.

2

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. McPherson S, et al. Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077. Gut. 2010. PMID: 20801772

3

How big a problem is non-alcoholic fatty liver disease?

Anstee QM, McPherson S, Day CP. Anstee QM, et al. Among authors: mcpherson s. BMJ. 2011 Jul 18;343:d3897. doi: 10.1136/bmj.d3897. BMJ. 2011. PMID: 21768191 No abstract available.

4

Cholestasis secondary to anabolic steroid use in young men.

Elsharkawy AM, McPherson S, Masson S, Burt AD, Dawson RT, Hudson M. Elsharkawy AM, et al. Among authors: mcpherson s. BMJ. 2012 Feb 2;344:e468. doi: 10.1136/bmj.e468. BMJ. 2012. PMID: 22302781 No abstract available.

5

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD. McPherson S, et al. Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf. Eur J Gastroenterol Hepatol. 2013. PMID: 23325287

6

Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease.

Scragg J, Avery L, Cassidy S, Taylor G, Haigh L, Boyle M, Trenell MI, Anstee QM, McPherson S, Hallsworth K. Scragg J, et al. Among authors: mcpherson s. Clin Transl Gastroenterol. 2020 Sep;11(9):e00231. doi: 10.14309/ctg.0000000000000231. Clin Transl Gastroenterol. 2020. PMID: 33094956 Free PMC article. Clinical Trial.

7

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.

Hallsworth K, McPherson S, Anstee QM, Flynn D, Haigh L, Avery L. Hallsworth K, et al. Among authors: mcpherson s. J Med Internet Res. 2021 Jan 15;23(1):e20491. doi: 10.2196/20491. J Med Internet Res. 2021. PMID: 33448929 Free PMC article.

8

The pathway to better primary care for chronic liver disease.

Jarvis H, McPherson S, Anstee QM, Hanratty B. Jarvis H, et al. Among authors: mcpherson s. Br J Gen Pract. 2021 Mar 26;71(705):180-182. doi: 10.3399/bjgp21X715553. Print 2021 Apr. Br J Gen Pract. 2021. PMID: 33771803 Free PMC article. No abstract available.

9

Embedding assessment of liver fibrosis into routine diabetic review in primary care.

Mansour D, Grapes A, Herscovitz M, Cassidy P, Vernazza J, Broad A, Anstee QM, McPherson S. Mansour D, et al. Among authors: mcpherson s. JHEP Rep. 2021 Apr 22;3(4):100293. doi: 10.1016/j.jhepr.2021.100293. eCollection 2021 Aug. JHEP Rep. 2021. PMID: 34179738 Free PMC article.

10

Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease.

Scragg J, Hallsworth K, Taylor G, Cassidy S, Haigh L, Boyle M, Anstee Q, McPherson S, Avery L. Scragg J, et al. Among authors: mcpherson s. BMJ Open Gastroenterol. 2021 Jul;8(1):e000678. doi: 10.1136/bmjgast-2021-000678. BMJ Open Gastroenterol. 2021. PMID: 34326098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

742 results

Search Page